Burkina Faso has slammed the brakes on a billion-dollar biotech experiment many claimed was the future of malaria eradication. On August 23, the country’s military-led government suspended the Bill Gates–backed Target Malaria project and ordered the destruction of genetically modified mosquitoes released into the wild.
The decision didn’t come out of nowhere. For years, scientists and philanthropists insisted gene-edited mosquitoes were a silver bullet against malaria, a disease that kills over 600,000 people annually—most of them in Africa. But in Burkina Faso, public skepticism never disappeared. Local critics called the project “unpredictable,” “irreversible,” and a dangerous gamble with ecosystems and human health.
Now, with rising distrust of Western influence and growing ties to Russia and Iran, the Burkinabé leadership is saying no more.
A Decade in the Making, Stopped Overnight
Target Malaria began in 2012 under the guidance of Imperial College London, armed with more than a decade of funding from the Bill and Melinda Gates Foundation. The idea was radical: engineer mosquitoes that produce mostly males, shrinking the overall population since only females bite and spread malaria.
In 2019, Burkina Faso became the first African country to release GMO mosquitoes into the wild. Regulatory bodies had given approval, and communities were told it was safe. But the experiment never shook off criticism from civil society groups, who saw it as foreign scientists using African soil as a lab.
Ali Tapsoba, a leading activist with the Coalition for Monitoring Biotechnological Activities, didn’t mince words: “This technology is highly controversial, unpredictable, and raises ethical concerns. Its impacts on ecosystems and human health remain unknown and potentially irreversible.”
A Clash of Science, Power, and Sovereignty
For Captain Ibrahim Traoré’s government, which seized power in 2022, the project became more than a health debate—it was about sovereignty. In the shadow of coups, foreign meddling, and a growing rejection of Western-backed NGOs, a high-profile Gates-funded operation was never going to survive unscathed.
Critics point to a deeper issue: “scientific colonialism.” Why should experiments designed in European labs, funded by U.S. billionaires, be unleashed first on African communities?
Global Shockwaves
Internationally, the suspension is being watched with alarm. Supporters say it could delay progress in the fight against malaria by decades. Detractors see it as a necessary reality check on billionaire-driven health experiments.
The Bill and Melinda Gates Foundation, long criticized for pushing GMO crops and industrial agriculture models in the Global South, has yet to comment. But the backlash is undeniable: a supposed miracle cure is now a symbol of distrust, power politics, and the battle over who controls Africa’s health future.
The Bigger Question
Burkina Faso’s move isn’t just about mosquitoes. It’s about whether solutions to Africa’s biggest health crises will be dictated by foreign billionaires and biotech labs—or by the people who live with the consequences.
For many, this is not progress—it’s bio-colonialism dressed up as philanthropy. And Burkina Faso just drew a line in the sand.
______________________________________________
Help Keep Independent Journalism Alive & Support a Senior
Even a small contribution to my GoFundMe helps me continue this work and get a used car to stay mobile.
